CN111867594A — 包含烷基硫酸钠的药物组合物
Assigned to Taiho Pharmaceutical Co Ltd · Expires 2020-10-30 · 6y expired
What this patent protects
本发明的目的是改善来自包含(S)‑1‑(3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基‑1‑吡咯烷基)‑2‑丙烯‑1‑酮的药物制剂中的有效地作为抗肿瘤药剂的(S)‑1‑(3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基‑1‑吡咯烷基)‑2‑丙烯‑1‑酮的溶解和吸收。提供包含(S)‑1‑(3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基‑1‑吡咯烷基)‑2‑丙烯‑1‑酮以及具有含有10至18个碳原子的烷基的烷基硫酸钠(特别是…
USPTO Abstract
本发明的目的是改善来自包含(S)‑1‑(3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基‑1‑吡咯烷基)‑2‑丙烯‑1‑酮的药物制剂中的有效地作为抗肿瘤药剂的(S)‑1‑(3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基‑1‑吡咯烷基)‑2‑丙烯‑1‑酮的溶解和吸收。提供包含(S)‑1‑(3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基‑1‑吡咯烷基)‑2‑丙烯‑1‑酮以及具有含有10至18个碳原子的烷基的烷基硫酸钠(特别是十二烷基硫酸钠)的药物组合物。
Drugs covered by this patent
- Lytgobi (futibatinib) · Taiho Oncology
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.